Vaccinex, Inc. to Host Key Opinion Leader Luncheon on Huntington’s Disease
January 30, 2018 11:14 ET
|
Vaccinex, Inc.
ROCHESTER, N.Y., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc., a privately-held clinical-stage biotechnology company engaged in the discovery and development of human therapeutic monoclonal...